A patient in her early 40s sat in my office with a binder. Inside the binder: three years of headache logs, every food trigger she had experimented with, the dates and outcomes of four different preventive medications, and printouts from two neurologists. Her headaches had a pattern she could not stop noticing — they clustered in the two days before her period and again at mid-cycle. Nobody had ever asked her about her cycle. She had asked. She had been told there was no good evidence the connection mattered.
There is, in fact, very good evidence the connection matters. The pattern she described is one of the most well-characterized hormonal headache presentations in clinical medicine, and a thoughtful evaluation of her sex hormones changed her life within four months. Her preventive medication regimen got smaller, not larger. She stopped tracking food triggers because they were never her actual triggers.
In my practice I see the hormone-migraine connection underestimated constantly — both by patients who have never connected the timing, and by providers who treat headaches as a purely neurological problem with no endocrine input. The neurology is real. The endocrine input is also real. When you ignore one of them, you treat the other one harder than you need to and the patient still loses days every month.
Why estrogen drops trigger headaches
Estradiol does several things in the brain that matter for migraine. It modulates serotonin tone. It regulates the excitability of the trigeminovascular system. It influences nitric oxide signaling in cerebral vessels. It interacts with CGRP — the calcitonin gene-related peptide pathway that the newer migraine medications target directly.
When estradiol drops sharply, all of those systems get destabilized at once. Serotonin tone falls. Trigeminal threshold drops. Vessels become more reactive. The brain is suddenly less protected against the cascade that produces a migraine.
The key word in that paragraph is "drops." It is not the absolute level of estradiol that triggers the headache. It is the rate of decline. A woman with chronically low estradiol may have fewer headaches than a woman whose estradiol swings from high to low across her cycle, because the brain adapts to a stable low better than it tolerates a drop from 200 to 40 over three days.
This is why menstrual migraine clusters in the late luteal phase and the first day or two of menses — the largest estrogen drop of the cycle. It is why estrogen-withdrawal headaches happen on the placebo week of a combined oral contraceptive. It is why perimenopausal headaches often get worse before they get better — the swings get bigger before the system finally settles into the postmenopausal floor.
Progesterone matters too, but in a different way. Progesterone metabolites, particularly allopregnanolone, are GABAergic. They have a calming, threshold-raising effect on the central nervous system. When progesterone drops, that braking system weakens. For women with anovulatory cycles in early perimenopause, the loss of luteal progesterone alone can drive a headache pattern that was never there before.
The patterns I see most
When I take a careful headache history alongside a cycle history, the patterns tend to sort into a few buckets.
Pure menstrual migraine. Headaches occurring within the window from two days before menses through the first three days of bleeding. These are almost always estrogen-withdrawal headaches, and they respond well to strategies that smooth the perimenstrual estrogen drop.
Mid-cycle migraine. Headaches clustering around ovulation. These reflect the sharp estradiol dip that occurs after the LH surge and before the early luteal estradiol rise. Less common than menstrual migraine but very recognizable when it shows up.
Perimenopausal pattern shift. A woman who has had migraines for years notices that the pattern is changing — frequency increasing, intensity changing, the cycle relationship blurring. This is what happens when ovulation becomes intermittent and the hormone landscape gets chaotic.
New-onset headache in the late 30s or 40s. A woman with no significant headache history starts having migraines for the first time. This is one of the presentations most likely to get worked up for everything except the hormonal driver. The labs are usually telling.
Combined oral contraceptive trigger. A woman whose headaches are worst on the placebo week. The fix is often as simple as a continuous cycling regimen or a different delivery method, but only if someone takes the cycle history.
A few of these patients have a confounder that needs separate attention — sleep apnea, untreated hypothyroidism, medication overuse headache, an actual structural problem. I am not the right provider to manage every headache. But the cycle pattern is almost always the missing piece in patients who have been worked up for everything else and are still losing days.
What I look for in the workup
When I evaluate a patient for hormonally driven headaches, the labs I want are not the labs a neurologist typically orders.
A timed estradiol and progesterone — drawn on a specific cycle day matched to the patient's pattern. A randomly drawn estradiol in a cycling woman tells you almost nothing.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
FSH and LH to assess where she is in the perimenopausal arc. A creeping FSH in a woman in her 40s with a worsening headache pattern is a meaningful finding.
Free and total testosterone with SHBG. Testosterone has been studied in migraine and the data is interesting — low free testosterone in women correlates with higher migraine burden. SHBG matters because of how it changes the bioavailable fraction.
Full thyroid including reverse T3 and antibodies. Hypothyroidism amplifies migraine in women, and subclinical Hashimoto's in this age group is common.
Magnesium RBC, vitamin D, and B12 — not because deficiencies are exotic but because they are common, addressable, and often part of the complete picture.
If the patient is on a combined oral contraceptive or a hormonal IUD, that goes into the analysis. If she is on a synthetic progestin, that is relevant — synthetic progestins do not have the same GABAergic profile as bioidentical progesterone and the headache implications are different.
How I approach treatment
Treatment depends on which pattern the workup reveals, but the general framework holds.
For menstrual migraine in a woman with intact cycles, the most useful lever is often perimenstrual estradiol support — a low-dose transdermal estradiol patch applied in the late luteal phase to blunt the perimenstrual drop. The dose is small. The intent is to soften the cliff, not flatten the cycle. Many patients see their menstrual migraine days drop by half or more within two cycles.
For perimenopausal headache shift, the conversation is different. Bioidentical progesterone in the luteal phase often helps with the sleep and anxiety component first, and patients frequently notice the headache pattern soften as a downstream effect. If estradiol is low and the symptoms warrant systemic estrogen, low-dose transdermal estradiol is my preferred delivery — oral estrogen is more variable in its effect on headache and the hepatic first-pass effect is unhelpful here.
For women already on a combined oral contraceptive whose headaches cluster on the placebo week, the simplest fix is often a continuous regimen that eliminates the withdrawal week entirely. For women with migraine with aura, combined oral contraceptives are contraindicated and the conversation shifts to non-estrogen contraception alongside cycle-supportive hormone strategies.
Hormone optimization for headache is not the same as hormone optimization for hot flashes. The dosing logic is different, the delivery preferences are different, and the reassessment cadence is tighter — I want to know what the headache log looks like at four weeks, eight weeks, and twelve weeks, not just whether the labs look right.
A note about Biote pellet therapy in this population: pellets produce stable serum levels and many headache patients do well on them once we have established the right dose with a more titratable delivery first. I am cautious about starting a headache patient on a pellet as the first intervention because pellets are not adjustable for three to four months. For some patients pellets are the right long-term answer; the path there usually runs through a more flexible starting protocol.
What I tell patients to expect
Within four to eight weeks, most patients with a clear hormonal pattern see meaningful change in either frequency or intensity — usually both. By three months we have enough data to know whether the dose is right. By six months we either have a stable plan that has reduced their headache burden substantially or we know we need to look at a different driver.
I do not promise zero headaches. I tell patients that a 50 to 70 percent reduction in headache days, with milder breakthrough events that respond to acute medication, is a realistic and common outcome when the hormonal driver was the dominant one. For patients whose hormonal contribution was smaller, the improvement is smaller but real, and the work shifts to the adjacent factors.
I coordinate with the patient's neurologist when there is one. Hormone optimization does not replace acute migraine medication or the established preventive options — it works alongside them, and patients commonly find their need for acute medication drops as the hormonal background stabilizes.
The next step
If your headaches have a cycle relationship — even one you have only half-noticed — that pattern is clinical information and it deserves a real workup. Bring your headache log if you have one. If you do not, start tracking now: date, intensity, cycle day, any other variables you can think of. Three cycles of data sharpens the picture enormously.
Bring any prior hormone labs. Bring the medication list, including birth control if you are on one. Bring your top three questions.
You can book a consultation at either the Columbus location or the Warner Robins location. The first visit covers the history and orders the comprehensive lab work if you do not have recent results timed to the right cycle days. The second visit is the data review and the treatment plan.
The cycle is the clue. If nobody has asked you about it in the context of your headaches, that is the conversation worth having.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.